Although tuberculosis is a preventable and curable disease, it is the major cause of death by a single infectious agent (3). Vaccination programs against tuberculosis have been established in many countries with the use of the attenuated strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG). However, the immunoprotective efficacy of BCG in different trials over several decades has varied, and its value as a tuberculosis vaccine remains controversial (4).
Although tuberculosis is a preventable and curable disease, it is the major cause of death by a single infectious agent (3) . Vaccination programs against tuberculosis have been established in many countries with the use of the attenuated strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG). However, the immunoprotective efficacy of BCG in different trials over several decades has varied, and its value as a tuberculosis vaccine remains controversial (4) .
Other mycobacterial strains which share cross-reactive antigens with Mycobacterium tuberculosis have also been considered as alternatives to M. bovis for vaccine use. One strain, Mycobacterium vaccae, has been tested as an immunotherapeutic agent in human tuberculosis (9, 14, 23) . M. vaccae given as a single injection to patients within the first few weeks of starting chemotherapy for pulmonary tuberculosis appeared to improve the cure rate and reduce the number of deaths (23) . Data from field studies suggest that M. vaccae should be investigated as an immunotherapeutic agent for tuberculosis patients who have not received adequate chemotherapy (24) . It may also be useful as adjunctive therapy for patients with multidrug-resistant tuberculosis (9) or who are additionally infected with the human immunodeficiency virus (22) . Compared with the results for control mice, immunization with heat-killed M. vaccae prior to infection of mice with M. tuberculosis reduced the number of mycobacterial CFU in spleens by one logarithm (1) .
The mechanism by which M. vaccae influences the immune response to M. tuberculosis infection is unclear. In tuberculous lesions, macrophages infected with M. tuberculosis are surrounded by activated T cells (7) . Both CD4 ϩ and CD8 ϩ T cells have been shown to lyse infected macrophages expressing mycobacterial antigens (8, 19) . Depletion of CD4 ϩ or CD8 ϩ T cells in mice with monoclonal antibodies exacerbates infection with M. tuberculosis (13) . Protection against infection can also be enhanced by the adoptive transfer of selected CD4 ϩ and CD8 ϩ T cells from infected mice (15) . Mice with disrupted major histocompatibility complex class I genes and thus deficient in CD8 ϩ T cells (11) or with disrupted gamma interferon (IFN-␥) or IFN-␥ receptor genes show increased susceptibility to tuberculosis (5, 25) . IFN-␥ also has an important role in immunity against human tuberculosis. Compared with healthy tuberculin reactors, lymphocytes from patients with tuberculosis showed diminished production of the Th1 cytokines, IFN-␥ and interleukin-12 (IL-12) (26) . At the same time there were no apparent changes in the production of the Th2 cytokines, IL-4, IL-10, and IL-13 (26) . Following treatment for tuberculosis and with clinical recovery, patients' lymphocytes increased their production of IFN-␥ (26) .
In this study, immune responses to M. tuberculosis are analyzed in mice which have been immunized with heat-killed M. vaccae. Two striking effects have been observed: stimulation of CD8 ϩ cytotoxic T cells specific for target cells infected with M. tuberculosis and a cytokine secretion profile for CD8 ϩ T cells that reflects a Th1 phenotype. The significance of these findings to a human vaccine is discussed.
MATERIALS AND METHODS
Mice. All experiments were performed using 6-to 8-week old specific pathogen-free BALB/c mice purchased from the Department of Laboratory and Animal Science, University of Otago, Dunedin, New Zealand.
Bacterial immunization and infections. M. vaccae (ATCC 15483) was cultured in sterile medium 90 (yeast extract, 2.5 g/liter; tryptone, 5 g/liter; glucose, 1 g/liter) at 37°C. The bacteria were then harvested by centrifugation and transferred into sterile Middlebrook 7H9 (Difco Laboratories, Detroit, Mich.) medium with glucose at 37°C for 1 day. Bacteria cultures were centrifuged to pellet the bacteria, and the culture supernatant was removed. The bacterial pellet was resuspended in phosphate-buffered saline (PBS) at a concentration of 10 mg/ml, equivalent to 10 10 bacilli per ml. IFN-␥ and IL-12 assays. IFN-␥ concentrations in culture supernatants were measured by an enzyme-linked immunosorbent assay (ELISA). The 96-well plates were coated with a rat monoclonal antibody directed to mouse IFN-␥ (R4-6A2; PharMingen, San Diego, Calif.) in PBS for 4 h at 4°C. Wells were blocked with PBS containing 0.2% Tween 20 for 1 h at room temperature. The plates were then washed four times in PBS-0.2% Tween 20, and samples diluted in culture medium in the ELISA plates were incubated overnight at room temperature. The plates were again washed, and a biotinylated monoclonal rat anti-mouse IFN-␥ antibody (XMG1.2; PharMingen) diluted to 100 ng/ml in PBS-10% FCS was added to each well. The plates were then incubated for 1 h at room temperature and washed, and horseradish peroxidase-coupled avidin D (vector 2004) was added at a 1:4,000 dilution in PBS. After a further 1-h incubation at room temperature, the plates were washed, and an o-phenylenediamine substrate was added. The reaction was stopped after 10 min with 10% (vol/vol) HCl. The optical density was determined at 495 nm.
IL-12 concentrations in culture supernatants were measured by a similar ELISA technique with a rat anti-mouse IL-12 (p40/p70) monoclonal antibody (C15.6; PharMingen) as the capture antibody and a biotinylated rat anti-mouse IL-12 (p40/p70) monoclonal antibody (C17.8; PharMingen) as the detecting antibody.
Isolation of CD4 ؉ and CD8 ؉ T cells. The spleen cells were passed through a CD4 ϩ or CD8 ϩ T-cell enrichment column (R&D Systems, Minneapolis, Minn.) according to the manufacturer's instructions. The spleen cells recovered from the column have been shown by flow cytometry to be enriched 85 to 90% for CD4 ϩ or CD8
ϩ T cells and contained less than 1% B cells and other major histocompatibility complex class II-positive cells, 1 to 2% ␥␦ T cells, and 2 to 3% natural killer (NK) cells.
In some experiments, spleen cells were cultured with heat-killed M. vaccae or M. tuberculosis for 6 days prior to the isolation of CD4 ϩ or CD8 ϩ T cells. Mice were injected with 1 ml of 3% thioglycolate i.p., and after 5 days macrophages were obtained from the peritoneal cavity. Macrophages were suspended in DMEM (without antibiotics)-10% FCS. The macrophages were infected with M. tuberculosis by culturing 10 5 macrophages per ml with 2 ϫ 10 5 bacilli overnight. After washing of these cultures, there were 1 to 5 mycobacteria per infected macrophage, at least 50% of which were infected. In the coculture experiments, 10 6 CD8 ϩ or CD4 ϩ T cells were cultured with 10 5 infected or uninfected macrophages in 200 l of DMEM (without antibiotics)-10% FCS for 72 h, after which the culture supernatants were harvested and assayed for IFN-␥ and IL-12.
Cytotoxicity assay. For use as targets in cytotoxic assays, infected or uninfected macrophages were labelled with chromium-51 sodium chromate at 2 Ci per 10 4 macrophages in 100 l of DMEM-10% FCS. The macrophages were washed and cultured overnight (16 h) with T cells enriched for CD4 ϩ or CD8 ϩ cells at various killer-to-target ratios. Specific killing was detected by the release of 51 Cr and expressed as the percentage of specific lysis, calculated from the counts per minute (cpm) by the following formula: [(cpm in test culture supernatant Ϫ cpm in control culture supernatant)/(total cpm Ϫ cpm in control culture supernatant)] ϫ 100%. splenocytes from mice immunized 2 weeks previously with M. vaccae. The specificity and potency of the CD8 ϩ CTLs were demonstrated by their ability to give 95% specific lysis of infected target cells at a killer-to-target cell ratio of 10:1, whereas the specific lysis of uninfected targets at this killer-to-target cell ratio was not detectable (Fig. 3) .
RESULTS

Antigen
For comparison, the CTL activity of CD4 ϩ -enriched splenocytes from mice immunized with M. vaccae was tested. These CD4 ϩ cells also lysed infected target cells but only achieved 40% specific lysis at a killer-to-target cell ratio of 50:1 (Fig. 3) . The CD4 ϩ -enriched CTLs also did not lyse uninfected macrophages. CD8
ϩ T cells isolated from spleens of mice at 3 and 4 weeks after immunization with M. vaccae were no longer cytotoxic for infected macrophages.
To determine whether CD8 ϩ CTLs detected 2 weeks after immunization with M. vaccae had given rise to memory cells, the following experiment was performed. Mice were immunized with 1 mg of heat-killed M. vaccae, and 3 weeks later spleen cells were prepared and restimulated in vitro with M. vaccae for 6 days. At that time, spleen cells were harvested and separated into two fractions. One fraction was tested directly for cytotoxicity against macrophages infected with M. tuberculosis and gave 25% specific lysis at a killer-to-target cell ratio of 30:1 (data not shown). The second fraction was passaged through a CD8 ϩ enrichment column prior to the cytotoxicity assay. The CD8
ϩ -enriched population gave 40% specific lysis at a killer-to-target cell ratio of 10:1 ( Table 1 ). The specific lysis of uninfected macrophages by these CTL was less than 10%.
IL-12 production in cocultures of CD8 ؉ T cell and macrophages. The ability of CD8 ϩ T cells from M. vaccae-immunized mice to influence IL-12 production was examined by the following experiment. Four groups of mice were immunized with 1 mg of heat-killed M. vaccae, and their spleens were removed at 1, 2, 3, or 4 weeks after immunization. CD8 ϩ T cells were prepared from the spleens and cocultured for 72 h with uninfected macrophages or macrophages infected with M. tuberculosis. In four separate experiments, cultures of 10 5 uninfected macrophages were found to secrete only 0 to 8 mice immunized with M. vaccae to the infected macrophage cultures increased the amount of IL-12 in the supernatants by two-to fourfold (Fig. 4) . The enhanced IL-12 secretion in the cocultures was noted after the addition of CD8 ϩ enriched cells obtained as early as one week following immunization and peaked with CD8 ϩ T cells prepared from spleens 3 weeks after immunization. There was no increase in IL-12 production in cocultures of CD8 ϩ T cells from mice immunized with M. vaccae and uninfected macrophages or in cocultures of naive CD8 ϩ T cells and infected macrophages.
Effect of immunization with M. vaccae on CD8
؉ T cells of mice infected with M. tuberculosis. Mice were immunized with 1 mg of heat-killed M. vaccae and 3 weeks later infected with 5 ϫ 10 5 CFU of M. tuberculosis. Their spleens were removed after a further 6 weeks. One fraction of splenic cells was passaged through a CD8 ϩ T-cell enrichment column, and splenic CD8 ϩ T cells were isolated. These freshly isolated CD8 ϩ T cells were cultured for 3 days with macrophages infected with M. tuberculosis, and the coculture supernatant was assayed for IFN-␥ and IL-12 production. The data in Table 2 reveal that the secretion levels of both IFN-␥ and IL-12 were similar in cocultures of infected macrophages with CD8 ϩ T cells from immunized and nonimmunized infected mice. The cytotoxicity of the freshly isolated splenic CD8 ϩ T cells was also assayed but found to lack activity cytolytic to macrophages infected with M. tuberculosis.
To determine whether the CD8 ϩ T-cell population contained precursors specific for M. tuberculosis, the second fraction of spleen cells removed 6 weeks after infection were cultured with heat-killed M. tuberculosis for 6 days, following which CD8 ϩ T cells were isolated. The restimulated CD8 ϩ T cells from infected mice produced similar amounts of IFN-␥ and IL-12 in the in vitro coculture response to infected macrophages, regardless of whether the CD8 ϩ T cells came from immunized or unimmunized mice. Restimulated CD8 ϩ T cells prepared from infected mice which had been immunized with M. vaccae resulted in the generation of cells that were specifically cytotoxic for infected macrophages ( Table 2 ). The restimulation of CD8 ϩ T cells prepared from nonimmunized infected mice did not develop cells cytotoxic for infected macrophages.
DISCUSSION
Prior exposure to various mycobacteria can potentially alter immune responses in a subsequent infection with M. tuberculosis. In this paper we describe the properties of M. tuberculosis-reactive CD8 ϩ T cells that are generated in mice immunized with heat-killed M. vaccae.
Two weeks following immunization of mice with heat-killed M. vaccae, CD8
ϩ T cells were found in spleens that were specifically cytotoxic for syngeneic macrophages infected with live M. tuberculosis but not for uninfected macrophages (Fig.  2) . However, this effector activity rapidly disappeared at 3 and 4 weeks following immunization; these effector CD8 ϩ CTLs were no longer found in the spleen. By incubating spleen cells in culture with M. vaccae, CD8
ϩ CTL activity reappeared. This finding suggests that the effector cells have reverted to a memory state and that with appropriate activation signals it is possible to stimulate M. vaccae-primed memory cells to effector CTLs capable of recognizing and killing M. tuberculosis-infected cells.
The CD8 ϩ CTLs were also strong producers of IFN-␥, and this cytokine profile indicates that these cells may be classed as the Tc1 type of CTLs (20) . In addition to secreting IFN-␥, CTLs from M. vaccae-immunized mice enhance IL-12 production in coculture with M. tuberculosis-infected macrophages. IL-12 is produced by macrophages early in the immune response, and it enhances IFN-␥ production by T cells. The CD8 ϩ T cells from as early as 1 week after immunization enhanced IL-12 production. The peak production of both IFN-␥ and IL-12 occurred 3 weeks after immunization with M. vaccae. This finding is consistent with the interdependence of IFN-␥-producing CD8 ϩ T cells and IL-12-producing macrophages (10) . Memory CD8 ϩ T cells restimulated with specific antigen were also capable of enhancing IL-12 when cocultured with infected macrophages. In these experiments, NK cells are present at 2 to 3% in the CD8 ϩ -enriched T-cell populations, but preliminary experiments indicate that 10-to 100-fold of this number of NK cells are required to account for the levels of IFN-␥ observed. If NK cells contributed to the enhancement of IFN-␥ secretion and the resulting CD8 ϩ Tc1 response, this cooperative role for NK cells was not evident in T-cell populations enriched for CD4 ϩ cells. The CTLs that appear in unimmunized mice following infection with M. tuberculosis differ from those generated in mice immunized with M. vaccae. Orme et al. detected in the spleens of mice infected with M. tuberculosis CD4 ϩ T cells cytotoxic for peritoneal macrophages pulsed with M. tuberculosis culture filtrate proteins (17) . M. tuberculosis-specific memory cells have been found in the CD4 ϩ splenic T-cell population (2). CD4 ϩ T cells from infected mice produce more IFN-␥ than does the CD8 ϩ T-cell subset (17) . This is in contrast to the results for the mice immunized with M. vaccae whose CD8 ϩ T We have also shown that the Tc1 characteristics of CD8 ϩ T cells from mice immunized with M. vaccae persist in mice after infection with M. tuberculosis. Six weeks after infection, the CD8 ϩ T cells from the spleens of immunized and unimmunized mice produced comparable amounts of IFN-␥ and IL-12 in response to M. tuberculosis-infected macrophages. As expected, no mycobacterium-specific CD8 ϩ effector CTLs were detected, presumably because such cells are distributed to organs other than the spleen or that at this stage the numbers of activated effector CTLs have subsided. However, memory-type CTLs specific for M. tuberculosis-infected macrophages were detected but only in spleens of mice immunized with M. vaccae.
There are numerous problems in the development of protective vaccines against tuberculosis or immunotherapy for patients with clinical disease. The first is defining the cellular components of a protective response. The second is the recall of these components when cells are confronted with infection and maintenance of dominance of appropriate effector mechanisms during the development of clinical disease. Experimental data from mice suggest that adoptively transferred T-cell clones that were the most effective at providing protection against M. tuberculosis infection were the ones that were most cytotoxic (21) . On the other hand, recent data from perforin and granzyme gene knockout mice suggest that the role of CD8 ϩ T cells in controlling M. tuberculosis infection may rely on mechanisms such as cytokine secretion and not on their lytic activity (6, 12) .
Experimental data from infected mice is often criticized because animals do not normally develop clinical disease. Nevertheless, the reasons why mice exhibit such resistance to this disease are important in understanding protective immunity. Experiments in the 1980s indicated that several nonliving mycobacterial preparations tested in vivo in mice conferred the ability to mount a delayed-type hypersensitivity response to tuberculin (18) . However, none of such preparations generated protective T cells capable of adoptive immunization against virulent tuberculosis (16) . The idea developed that immunity to live mycobacteria was not directed against constitutive proteins but against proteins secreted by live organisms. It is thus striking that in mice immunized with heat-killed M. vaccae the number of mycobacteria in spleens was reduced following infection with live M. tuberculosis (1) .
There are two aspects to the experiments described here. The first is that heat-killed M. vaccae stimulates CD8 ϩ T cells which are specifically cytotoxic for syngeneic macrophages infected with live M. tuberculosis and thus retains antigens which are cross-reactive with those of live M. tuberculosis. The second is that the use of heat-killed M. vaccae stimulates CD8 ϩ T cells which secrete IFN-␥ and enhance IL-12 production by infected macrophages. Recently, Abou-Zeid et al. showed that immunization of mice with heat-killed recombinant M. vaccae expressing the 19-kDa lipoprotein of M. tuberculosis is more effective than immunization with the same antigen in incomplete Freund's adjuvant in producing an antigen-specific Th1 response (1). These observations suggest that heat-killed M. vaccae also contains adjuvant substances which preferentially stimulate T cells with a Th1 cytokine secretion profile. Immunization with heat-killed M. vaccae appears to promote the dominance of IL-12, IFN-␥, and the Tc1 loop.
Our data provide the immunologic basis for defining further the components of M. vaccae that may be useful as a vaccine for tuberculosis. It is not clear whether the antigenic and adjuvant properties of M. vaccae reside within the same molecular component. The enhancement of the CD8 ϩ T-cell subset may be a significant advantage for M. vaccae over M. tuberculosis or other mycobacterial strains in immunizations. Although whole autoclaved M. vaccae may be effective, it is possible that selected antigenic proteins and adjuvant components may perform better as vaccines due to their Th1-or Tc1-inducing properties. We are currently cloning the genes of several M. vaccae proteins for development in protein-based subunit vaccines or as DNA vaccines.
